QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

GRFS

QT67Grifols, S.A.
NASDAQ·Healthcare·Drug Manufacturers - General·ES
Latest market price
7.40
-0.06-0.80%
OverviewShort InterestFilings
GRFSQT67Grifols, S.A.·NASDAQ
OverviewShort InterestFilings
7.40-0.80%
TA
Loading chart...
Screen all →
LLY-1.21%$1098.57JNJ-2.48%$228.39ABBV-2.08%$216.63NVS-2.52%$147.08MRK-1.36%$113.87AZN-1.66%$174.93NVO-0.76%$43.19AMGN-1.19%$337.60
Snapshot
Index-P/E14.62EPS (ttm)0.71
Insider Own-
Shs Outstand687.55M
Perf Week-1.20%
Market Cap6.96BForward P/E5.97EPS next Y1.24Insider Trans-Shs Float-Perf Month-5.61%
Enterprise Value17.24BPEG0.12EPS next Q0.32Inst Own-Short Float-Perf Quarter-4.76%
Income476.14MP/S0.82EPS this Y35.21%Inst Trans-Short Ratio-Perf Half Y-17.41%
Sales8.53BP/B1.11EPS next Y29.21%ROA2.07%Short Interest-Perf YTD-20.86%
Book/sh13.21P/C5.94EPS next 5Y18.78%ROE7.88%52W High11.14 -33.57%Perf Year-16.57%
Cash/sh1.18P/FCF8.05EPS past 3/5Y-ROIC5.49%52W Low7.26 1.93%Perf 3Y-
Dividend Est.0.18 (2.38%)EV/EBITDA10.50Sales past 3/5Y8.53% 6.01%Gross Margin37.68%Volatility1.33% 1.63%Perf 5Y-
Dividend TTM0.18 (2.38%)EV/Sales2.02EPS Y/Y TTM249.91%Oper. Margin16.89%ATR (14)0.19Perf 10Y-
Dividend Ex-DateAug 12, 2025Quick Ratio0.85Sales Y/Y TTM10.64%Profit Margin5.58%RSI (14)39.79Recom2.75
Dividend Gr. 3/5Y- 4.19%Current Ratio2.47EPS Q/Q73.10%SMA20-3.41%Beta0.95Target Price-
Payout30.83%Debt/Eq1.77Sales Q/Q7.72%SMA50-6.98%Rel Volume1.53Prev Close7.46
Employees23,833LT Debt/Eq1.10EarningsJul 23SMA200-15.70%Avg Volume670.23KPrice7.40
IPO DateJun 02, 2011Option/ShortYes / YesEPS/Sales Surpr.7.32% -1.43%Net Debt/EBITDA6.26Volume1,025,910Change-0.80%
Analyst Ratings
DateActionAnalystRatingTarget
Mar-12-24DowngradeDeutsche BankHold → Sell
Nov-05-21DowngradeDeutsche BankBuy → Hold
Mar-23-21UpgradeCredit SuisseNeutral → Outperform
Mar-11-21UpgradeHSBCHold → Buy
Oct-28-19UpgradeSantanderHold → Buy
Jun-27-19UpgradeJP MorganNeutral → Overweight
Feb-08-19DowngradeBerenbergBuy → Hold
Feb-09-16UpgradeBerenbergHold → Buy
Jan-04-16DowngradeMorgan StanleyEqual Weight → Underweight
Dec-02-15DowngradeHSBCBuy → Hold
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue8,6338,1537,803
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A5,3805,2434,780
Gross Profit3,2522,9113,023
Selling, General and Administrative Excl. Other1,2921,1521,238
Research and Development487404415
Other Operating Expense161581
Operating Income1,4561,3391,290
Interest Expense692677836
Unusual Expense
———
Non-Operating Income (Expense)55-4157
Net Income Before Taxes709666480
Income Taxes135125250
Consolidated Net Income481436170
Net Income From Continuing Operations575542230
Net Income481436170
EPS (Recurring)0.710.640.25
EPS (Basic, Before Extraordinaries)0.710.640.25
EPS (Diluted)0.710.640.25
EBITDA1,8101,8311,606
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio10.4214.54—
Price To Sales Ratio0.580.78—
Gross Margin37.6735.7038.74
Operating Margin16.8716.4216.53
Net Margin5.575.352.18
Shares Outstanding681681680
Market Capitalization5,0396,367—
Operating Lease Expense
———
Insider Trading Volume
$7.90$7.17$6.44$5.71$4.98● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR